BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36787501)

  • 1. Introduction to a review series on germ line predisposition to hematologic malignancies: time to consider germ line testing.
    Cazzola M
    Blood; 2023 Mar; 141(13):1509-1512. PubMed ID: 36787501
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
    Rajput RV; Arnold DE
    Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome.
    Cavalcante de Andrade Silva M; Katsumura KR; Mehta C; Velloso EDRP; Bresnick EH; Godley LA
    Leukemia; 2021 Jan; 35(1):264-268. PubMed ID: 32286542
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloid malignancies with somatic
    Alfayez M; Wang SA; Bannon SA; Kontoyiannis DP; Kornblau SM; Orange JS; Mace EM; DiNardo CD
    Leuk Lymphoma; 2019 Aug; 60(8):2025-2033. PubMed ID: 30648453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline
    Purgatorio G; Piselli E; Guglielmini G; Falcinelli E; Bury L; Di Battista V; Pellanera F; Milano F; Matteucci C; Mecucci C; Gresele P
    Haematologica; 2022 May; 107(5):1072-1085. PubMed ID: 34233447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?
    Bresnick EH; Jung MM; Katsumura KR
    Blood Adv; 2020 Sep; 4(18):4584-4592. PubMed ID: 32960960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
    Drazer MW; Kadri S; Sukhanova M; Patil SA; West AH; Feurstein S; Calderon DA; Jones MF; Weipert CM; Daugherty CK; Ceballos-López AA; Raca G; Lingen MW; Li Z; Segal JP; Churpek JE; Godley LA
    Blood Adv; 2018 Jan; 2(2):146-150. PubMed ID: 29365323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency.
    Catto LFB; Borges G; Pinto AL; Clé DV; Chahud F; Santana BA; Donaires FS; Calado RT
    Blood; 2020 Aug; 136(8):1002-1005. PubMed ID: 32556109
    [No Abstract]   [Full Text] [Related]  

  • 11. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
    Kozyra EJ; Pastor VB; Lefkopoulos S; Sahoo SS; Busch H; Voss RK; Erlacher M; Lebrecht D; Szvetnik EA; Hirabayashi S; Pasaulienė R; Pedace L; Tartaglia M; Klemann C; Metzger P; Boerries M; Catala A; Hasle H; de Haas V; Kállay K; Masetti R; De Moerloose B; Dworzak M; Schmugge M; Smith O; Starý J; Mejstrikova E; Ussowicz M; Morris E; Singh P; Collin M; Derecka M; Göhring G; Flotho C; Strahm B; Locatelli F; Niemeyer CM; Trompouki E; Wlodarski MW;
    Leukemia; 2020 Oct; 34(10):2673-2687. PubMed ID: 32555368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
    Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
    Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic heterogeneity associated with germline
    Haddox CL; Carr RM; Abraham RS; Perez Botero J; Rodriguez V; Pardanani A; Patnaik MM
    Leuk Lymphoma; 2019 Dec; 60(13):3282-3286. PubMed ID: 31246134
    [No Abstract]   [Full Text] [Related]  

  • 14. Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.
    Oleaga-Quintas C; de Oliveira-Júnior EB; Rosain J; Rapaport F; Deswarte C; Guérin A; Sajjath SM; Zhou YJ; Marot S; Lozano C; Branco L; Fernández-Hidalgo N; Lew DB; Brunel AS; Thomas C; Launay E; Arias AA; Cuffel A; Monjo VC; Neehus AL; Marques L; Roynard M; Moncada-Vélez M; Gerçeker B; Colobran R; Vigué MG; Lopez-Herrera G; Berron-Ruiz L; Méndez NHS; O'Farrill Romanillos P; Le Voyer T; Puel A; Bellanné-Chantelot C; Ramirez KA; Lorenzo-Diaz L; Alejo NR; de Diego RP; Condino-Neto A; Mellouli F; Rodriguez-Gallego C; Witte T; Restrepo JF; Jobim M; Boisson-Dupuis S; Jeziorski E; Fieschi C; Vogt G; Donadieu J; Pasquet M; Vasconcelos J; Ardeniz FO; Martínez-Gallo M; Campos RA; Jobim LF; Martínez-Barricarte R; Liu K; Cobat A; Abel L; Casanova JL; Bustamante J
    J Clin Immunol; 2021 Apr; 41(3):639-657. PubMed ID: 33417088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
    Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
    Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar Proteinosis, Infectious Complications and Monocytopenia Associated with GATA2 Deficiency.
    Raffáč Š; Aljubouri MAS; Gabzdilová J
    Neuro Endocrinol Lett; 2021 Jan; 41(6):290-295. PubMed ID: 33714240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
    Hamadou WS; Mani R; Besbes S; Bourdon V; Youssef YB; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
    Ann Hematol; 2017 Oct; 96(10):1635-1639. PubMed ID: 28752392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging.
    Abdelfattah A; Hughes-Davies A; Clayfield L; Menendez-Gonzalez JB; Almotiri A; Alotaibi B; Tonks A; Rodrigues NP
    Blood Adv; 2021 Oct; 5(20):4285-4290. PubMed ID: 34496012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
    Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
    Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline GATA2 Mutation and Bone Marrow Failure.
    McReynolds LJ; Calvo KR; Holland SM
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.